Wnt/NR2F2/GPX4 promoted acquired chemo‐resistance by suppressing ferroptosis with high consumption of GSH and GPX4 inhibitor was found to enhance the anticancer effect of platinum drugs in lung cancer BM, providing novel strategies for lung cancer patients with BM. Here, NR2F2 is linked to lung cancer.